Veeva Systems Hosts Biopharma Summit in Europe

May 27, 2025
Veeva Systems will host the Veeva R&D and Quality Summit in Madrid, featuring keynotes from industry leaders like Bayer and Novo Nordisk.

Veeva Systems will host the Veeva R&D and Quality Summit in Madrid, Spain, on June 4-5, 2025. The event will feature keynotes from leaders in the biopharma industry, including Bayer, Lonza, MSD, Novo Nordisk, Recipharm, and Teva. These sessions will explore how connected platforms and AI can enhance the development and manufacturing of new medicines, announced in a press release.

The summit will bring together over 1,400 industry professionals for more than 100 sessions, focusing on advancements in clinical, regulatory, safety, and quality sectors. A major highlight will be the introduction of Veeva AI, an initiative to integrate AI into the Veeva Vault Platform to automate critical functions and improve productivity.

Keynote speakers will discuss various topics, such as Bayer's approach to streamlining clinical infrastructure, Lonza's reshaping of quality management, and MSD's innovations in pharmacovigilance. Novo Nordisk will share insights on accelerating clinical trials, while Teva will highlight its data-driven strategies for navigating regulatory changes.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.